Related Experiment Video

Updated: Aug 24, 2026

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

Clinical ototoxicity of teicoplanin

Raymond M Bonnet1, Herman Mattie, Jan A P M de Laat

  • 1Department of Ear, Nose, and Throat Surgery, Leiden University Medical Center, Leiden, The Netherlands.

The Annals of Otology, Rhinology, and Laryngology
|April 29, 2004
PubMed

Insights

Teicoplanin may pose an ototoxicity risk, contrary to previous assumptions. This study found hearing thresholds worsened with teicoplanin, while cloxacillin showed improvement, suggesting a need to re-evaluate teicoplanin

Area of Science:

  • Ototoxicity research
  • Antibiotic safety
  • Clinical audiology

Background:

  • Previous literature suggests limited evidence of teicoplanin ototoxicity.
  • Conservative definitions of ototoxicity may have underestimated potential risks.
  • Comparative studies with non-ototoxic antibiotics are needed.

Purpose of the Study:

  • To compare the ototoxicity of teicoplanin with cloxacillin.
  • To assess hearing threshold changes over time in patients receiving these antibiotics.
  • To investigate potential underestimation of teicoplanin's ototoxic risk.

Main Methods:

  • Prospective audiometric evaluation of patients undergoing antibiotic treatment.
  • Comparison of hearing thresholds between teicoplanin and cloxacillin treatment groups.
  • Statistical analysis using a linear mixed-effects model.

Main Results:

  • Teicoplanin treatment was associated with a slight but significant increase in hearing thresholds over time.
  • Cloxacillin treatment showed a significant decrease in hearing thresholds.
  • Hearing improvement in the cloxacillin group may be linked to clinical recovery.

Conclusions:

  • Teicoplanin may have a greater ototoxic potential than previously reported.
  • Current definitions of ototoxicity might not fully capture teicoplanin's effects.
  • Further investigation into teicoplanin's ototoxicity is warranted.

More Related Videos

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration12:21

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration

Published on: November 26, 2015

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice09:06

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice

Published on: January 9, 2019

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...